Insider Transactions in Q4 2022 at Lucira Health, Inc. (LHDX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2022
|
Anthony Joseph Allen Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
4,263
-2.86%
|
$0
$0.16 P/Share
|
|
Dec 14
2022
|
Epiq Capital Group, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
982,417
+44.38%
|
-
|
|
Dec 14
2022
|
Epiq Capital Group, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
13,124,349
-61.98%
|
-
|
|
Dec 01
2022
|
Richard Clavano Narido Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,583
-1.45%
|
$0
$0.36 P/Share
|
|
Nov 28
2022
|
Ghazi Kashmolah Ex VP & Chief Quality Officer |
SELL
Open market or private sale
|
Direct |
7,537
-5.14%
|
$0
$0.42 P/Share
|
|
Nov 27
2022
|
Kevin Walter Collins Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
9,666
-2.71%
|
$0
$0.42 P/Share
|
|
Nov 21
2022
|
Anthony Joseph Allen Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
34,429
-9.54%
|
$0
$0.33 P/Share
|
|
Nov 17
2022
|
Ghazi Kashmolah Ex VP & Chief Quality Officer |
SELL
Open market or private sale
|
Direct |
33,247
-9.57%
|
$0
$0.38 P/Share
|
|
Nov 16
2022
|
Ghazi Kashmolah Ex VP & Chief Quality Officer |
SELL
Open market or private sale
|
Direct |
4,790
-2.59%
|
$0
$0.35 P/Share
|